Considering previously described increase in the eNPP1 expression in CAVD [22], we assume that the decreased ATP hydrolysis on the fibrosa surface of stenotic valve observed in our study is the effect of diminished CD39 activity, which expression was reduced in stenotic valves. The gene discussed is ENPP1; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.